
Acute Respiratory Distress Syndrome market to grow 3.8% CAGR through 2036 with new therapies emerging
The Acute Respiratory Distress Syndrome (ARDS) market is projected to grow steadily at a 3.8% CAGR through 2036, driven by rising ARDS cases and the development of innovative therapies like MultiStem, ExoFlo, and ThyrOxy. The US leads the market with...


